Dr Ana Đurić Ex Mariokov and Dr Milena Cavic performed a stakeholder visit to the R&I Company CeGaT GmbH in Tubingen, Germany on May 17, 2024, alongside selected clinicians and researchers from Serbia. CeGaT staff presented their facilities and the wide range of their activities in the field of genetic diagnostics, genetic counseling and diseases diagnostics. Possibilities for collaboration in the field of translational oncology regarding sequencing services, liquid biopsy, immune cell profiling and different research and pharma solutions were also outlined.
The visit opened up new opportunities for joint project applications between the IORS and successful R&I companies with a great impact on the benefit of Serbian cancer patients.
